Previous 10 | Next 10 |
2024-01-31 08:41:21 ET DENVER, Colo., Jan. 31, 2023 ( www.247marketnews.com )- Guardion Health Sciences, Inc. (NASDAQ: GHSI) reported, after yesterday’s market close, that it signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary and its Viactiv brand a...
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary, which owns the Viactiv ® ...
2024-01-08 13:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-11 02:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-14 01:39:20 ET More on Guardion Health Sciences Seeking Alpha’s Quant Rating on Guardion Health Sciences Historical earnings data for Guardion Health Sciences Financial information for Guardion Health Sciences For further details see: Guard...
Viactiv ® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022 HOUSTON, TEXAS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (&...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Guardion Health Sciences Inc. (GHSI) is expected to report for Q1 2024
2023-08-14 12:52:20 ET Guardion Health Sciences press release ( NASDAQ: GHSI ): Q2 GAAP EPS of -$0.93 in-line. Revenue of $2.79M (-14.7% Y/Y) beats by $0.01M . For further details see: Guardion Health Sciences GAAP EPS of -$0.93 in-line, revenue of $2.79M bea...
HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumer...
News, Short Squeeze, Breakout and More Instantly...
Guardion Health Sciences Inc. Company Name:
GHSI Stock Symbol:
NYSE Market:
Guardion Health Sciences Inc. Website:
2024-07-21 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-11 20:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of co...